Sandra E. Talbird

624 total citations
52 papers, 442 citations indexed

About

Sandra E. Talbird is a scholar working on Epidemiology, Infectious Diseases and Health. According to data from OpenAlex, Sandra E. Talbird has authored 52 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Epidemiology, 16 papers in Infectious Diseases and 16 papers in Health. Recurrent topics in Sandra E. Talbird's work include Vaccine Coverage and Hesitancy (16 papers), Pneumonia and Respiratory Infections (15 papers) and Influenza Virus Research Studies (9 papers). Sandra E. Talbird is often cited by papers focused on Vaccine Coverage and Hesitancy (16 papers), Pneumonia and Respiratory Infections (15 papers) and Influenza Virus Research Studies (9 papers). Sandra E. Talbird collaborates with scholars based in United States, United Kingdom and Belgium. Sandra E. Talbird's co-authors include Anita J. Brogan, Josephine Mauskopf, Elizabeth M. La, Justin Carrico, Thomas N. Taylor, Baudouin Standaert, Afisi Ismaila, Cosmina Hogea, Jessica K. DeMartino and Beate Sander and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Gastroenterology.

In The Last Decade

Sandra E. Talbird

47 papers receiving 434 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra E. Talbird United States 14 270 129 127 62 47 52 442
Heini Salo Finland 12 272 1.0× 140 1.1× 220 1.7× 38 0.6× 91 1.9× 30 531
Fabio Lievano United States 14 369 1.4× 187 1.4× 143 1.1× 73 1.2× 15 0.3× 24 601
Pedro Plans-Rubió Spain 14 326 1.2× 256 2.0× 132 1.0× 45 0.7× 26 0.6× 27 545
Karen Noakes Australia 7 354 1.3× 180 1.4× 102 0.8× 45 0.7× 62 1.3× 11 520
Larry Pickering United States 2 443 1.6× 183 1.4× 151 1.2× 113 1.8× 73 1.6× 2 649
Tarik Derrough Sweden 13 327 1.2× 152 1.2× 164 1.3× 22 0.4× 46 1.0× 24 535
Nancy Thiry United States 14 334 1.2× 78 0.6× 46 0.4× 50 0.8× 74 1.6× 67 646
Camilla Hiul Suppli Denmark 6 403 1.5× 134 1.0× 50 0.4× 86 1.4× 20 0.4× 9 499
Emilia Tiscione Italy 16 424 1.6× 206 1.6× 153 1.2× 78 1.3× 121 2.6× 39 561
Maria Giovanna Cappelli Italy 10 204 0.8× 156 1.2× 75 0.6× 47 0.8× 21 0.4× 18 349

Countries citing papers authored by Sandra E. Talbird

Since Specialization
Citations

This map shows the geographic impact of Sandra E. Talbird's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra E. Talbird with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra E. Talbird more than expected).

Fields of papers citing papers by Sandra E. Talbird

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra E. Talbird. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra E. Talbird. The network helps show where Sandra E. Talbird may publish in the future.

Co-authorship network of co-authors of Sandra E. Talbird

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra E. Talbird. A scholar is included among the top collaborators of Sandra E. Talbird based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra E. Talbird. Sandra E. Talbird is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carrico, Justin, Sandra E. Talbird, André Bento‐Abreu, et al.. (2023). Public health impact and return on investment of Belgium’s pediatric immunization program. Frontiers in Public Health. 11. 1032385–1032385. 6 indexed citations
3.
4.
Brogan, Anita J., et al.. (2021). The Cost-Effectiveness and Budget Impact of Ibalizumab-uiyk for Adults with Multidrug-Resistant HIV-1 Infection in the United States. PharmacoEconomics. 39(4). 421–432. 3 indexed citations
5.
Carrico, Justin, Sandra E. Talbird, Elizabeth M. La, et al.. (2021). Cost-benefit analysis of vaccination against four preventable diseases in older adults: Impact of an aging population. Vaccine. 39(36). 5187–5197. 14 indexed citations
6.
Anderson, Seri, et al.. (2021). Antiseizure medications and oral contraceptives: Impact of enzyme inducers on pregnancy outcomes and costs. Epilepsy & Behavior. 125. 108368–108368. 4 indexed citations
7.
Herring, William L., Yuanhui Zhang, Vivek Shinde, et al.. (2021). Clinical and economic outcomes associated with respiratory syncytial virus vaccination in older adults in the United States. Vaccine. 40(3). 483–493. 26 indexed citations
8.
Talbird, Sandra E., Elizabeth M. La, Justin Carrico, et al.. (2020). Impact of population aging on the burden of vaccine-preventable diseases among older adults in the United States. Human Vaccines & Immunotherapeutics. 17(2). 332–343. 37 indexed citations
10.
Standaert, Baudouin, Ilse Van Vlaenderen, Sandra E. Talbird, et al.. (2019). Constrained Optimization for the Selection of Influenza Vaccines to Maximize the Population Benefit: A Demonstration Project. Applied Health Economics and Health Policy. 18(4). 519–531. 9 indexed citations
11.
Talbird, Sandra E., Elizabeth M. La, Justin Carrico, et al.. (2018). PIN25 - PROJECTED BURDEN OF VACCINE-PREVENTABLE DISEASES IN OLDER ADULTS IN THE UNITED STATES: IMPACT OF POPULATION AGING. Value in Health. 21. S225–S225. 1 indexed citations
12.
Talbird, Sandra E., et al.. (2015). Review of cost-effectiveness analyses of varicella vaccination: which model structure assumptions and input parameters matter?. Value in Health. 18(3). A14–A15. 1 indexed citations
14.
Odom, Dawn, Anita J. Brogan, Sandra E. Talbird, & Brad Schenkel. (2013). A network meta-analysis of randomized, controlled trials of ustekinumab and adalimumab for moderate-to-severe psoriasis. Value in Health. 16(3). A112–A112. 3 indexed citations
15.
Mauskopf, Josephine, Anita J. Brogan, Sandra E. Talbird, & Susan Martin. (2011). Cost-effectiveness of combination therapy with etravirine in treatment-experienced adults with HIV-1 infection. AIDS. 26(3). 355–364. 18 indexed citations
16.
Brogan, Anita J., Sandra E. Talbird, & Calvin Cohen. (2011). Cost-Effectiveness of Nucleoside Reverse Transcriptase Inhibitor Pairs in Efavirenz-Based Regimens for Treatment-Naïve Adults with HIV Infection in the United States. Value in Health. 14(5). 657–664. 9 indexed citations
17.
Talbird, Sandra E., Thomas N. Taylor, Joaquín Caporale, Afisi Ismaila, & Jorge A. Gómez. (2010). Residual economic burden of Streptococcus pneumoniae- and nontypeable Haemophilus influenzae- associated disease following vaccination with PCV-7: A multicountry analysis. Vaccine. 28. G14–G22. 16 indexed citations
18.
Talbird, Sandra E., et al.. (2010). Outcomes and costs associated with PHiD-CV, a new protein D conjugate pneumococcal vaccine, in four countries. Vaccine. 28. G23–G29. 28 indexed citations
19.
Standaert, Baudouin, Nadia Demarteau, Sandra E. Talbird, & Josephine Mauskopf. (2010). Modelling the effect of conjugate vaccines in pneumococcal disease: Cohort or population models?. Vaccine. 28. G30–G38. 15 indexed citations
20.
Talbird, Sandra E., et al.. (2009). Oseltamivir for Influenza Postexposure Prophylaxis. American Journal of Preventive Medicine. 37(5). 381–388. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026